Skip to content

Kyntra Bio, Inc.

KYNB· NasdaqCore metricsCIK 921299

Pharmaceutical preparations552 peers

Last sale
Oct 23, 2026 · -7.09%
Market cap
$19.64M
4.05M shares
Filings
1,018
$1.76M
Q3 2026−78.3% FY25 yoy
$157.00K
Q3 2026N/M FY25 yoy
-$12.87M
Q3 2026N/M FY25 yoy
-$30.12M
Q3 2026derivedN/M FY25 yoy
$0.04
Q3 2026N/M FY25 yoy
$9.91M
Q3 2026−5.2% FY25 yoy
$19.64M
—
3.7×
—
-246.67%
—

Twelve months to Sep 30, 2026 · derived

Price

$4.8555.22%$5.98past year
Oct 23, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$6.44MFY 2025
$256.58M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$6,440,000reported
FY 20242024-12-31$29,621,000reported
FY 20232023-12-31$46,803,000 revisedreported
FY 20222022-12-31$140,734,000reported
FY 20212021-12-31$235,309,000reported
FY 20202020-12-31$176,319,000reported
FY 20192019-12-31$256,577,000reported
FY 20182018-12-31$212,958,000reported
FY 20172017-12-31$130,996,000 revisedreported
FY 20162016-12-31$183,189,000 revisedreported
FY 20152015-12-31$180,828,000reported
FY 20142014-12-31$137,601,000reported

Segments

Revenue by Geography, FY2018 to FY2025FY2018Europe · FY2018 · $112.92MJapan · FY2018 · $100.00MAll other · FY2018 · $40.00KFY2019Europe · FY2019 · $145.64MChina · FY2019 · $20.97MU.S. · FY2019 · $113.13MAll other · FY2019 · $2.00KFY2020Europe · FY2020 · $17.95MJapan · FY2020 · $19.82MChina · FY2020 · $73.36MU.S. · FY2020 · $65.18MFY2021Europe · FY2021 · $131.24MJapan · FY2021 · $2.31MChina · FY2021 · $55.64MU.S. · FY2021 · $46.12MFY2022Europe · FY2022 · $33.82MJapan · FY2022 · $9.76MChina · FY2022 · $84.63MU.S. · FY2022 · $12.52MFY2023Europe · FY2023 · $9.55MJapan · FY2023 · $15.87MChina · FY2023 · $8.43MU.S. · FY2023 · $12.96MFY2024Europe · FY2024 · $6.27MChina · FY2024 · $91.00KU.S. · FY2024 · $26.11MFY2025Europe · FY2025 · $5.64MJapan · FY2025 · $797.00K
LineFY2025ShareChange
Europe$5.64M88%−10.0%
Japan$797.00K12%N/M
China$0.00—−100.0%
U.S.$0.00—−100.0%
All other———
Total$6.44M

From the 10-K filed Mar 16, 2026KYNB

Pharmaceutical preparations

Kyntra Bio, Inc. is the 184th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR